antibody-recruiting molecules targeting urokinase plasminogen activator receptor (Kleo Pharmaceuticals)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameantibody-recruiting molecules targeting urokinase plasminogen activator receptor (Kleo Pharmaceuticals)
Drug Alias Nameantibody-recruiting molecules targeting urokinase plasminogen activator receptor (Yale University)ARMU-15ARM-U
ClassificationSmall molecules
Mechanisms of ActionUrokinase plasminogen activator modulators
TargetsUrokinase plasminogen activator
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesYale University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesYale UniversityKleo Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A